What is N-Acetyl Selank?
N-Acetyl Selank is a synthetic peptide derived from Selank, itself an analog of the endogenous immunomodulatory peptide tuftsin. Originally developed in Russia for anxiety and stress-related conditions, Selank has a well-established anxiolytic and nootropic profile. The N-Acetyl modification significantly improves upon the base compound by enhancing its half-life, bioavailability, and ability to cross the blood-brain barrier, making it considerably more effective per dose. It works primarily through modulation of dopamine, serotonin, and BDNF signaling, and also influences immune and inflammatory pathways including IL-6 expression. Delivered via nasal spray for efficient central nervous system access, N-Acetyl Selank is one of the cleaner anxiolytic options available due to its lack of sedation and dependence risk.
Mechanisms of Action
Serotonergic and dopaminergic modulation by influencing the release and regulation of these key neurotransmitters, contributing to its anxiolytic effects and mood-stabilizing properties
BDNF upregulation supporting neuronal growth, synaptic plasticity, and long-term cognitive function through increased brain-derived neurotrophic factor expression
IL-6 expression modulation reducing certain inflammatory signaling pathways that contribute to pain perception and stress-related immune dysregulation
GABAergic system interaction with Selank showing activity at GABA-related pathways, contributing to its calming effects without producing the sedation or dependency risk associated with classical GABAergic drugs
Enhanced CNS penetration via N-Acetyl modification allowing more efficient blood-brain barrier crossing and a longer effective window compared to unmodified Selank
Benefits
Anxiety reduction its primary and most well-documented effect, with meaningful reductions in both generalized anxiety and situational social anxiety reported by users in high-pressure contexts like interviews, first dates, and public performance
Stress management particularly relevant for individuals under sustained physical and psychological load, where Selank's anxiolytic activity can help maintain composure and recovery quality
Cognitive performance and memory with users reporting improved focus, sharper mental clarity, and better information retention, attributed to BDNF upregulation and neurotransmitter optimization
Pain perception reduction via IL-6 modulation, offering a secondary anti-inflammatory benefit that may be relevant during intense training periods
Anticoagulant activity with Selank showing some influence on blood coagulation pathways, though this is a secondary consideration rather than a primary use case
Dosing
Level | Dose | Frequency |
|---|---|---|
Starting | 1 spray per nostril | 2 to 3 times per day |
Working | 2 sprays per nostril | 2 to 3 times per day |
Due to its shorter half-life, redosing throughout the day is important for sustained anxiolytic coverage. Start with one spray per nostril 2 to 3 times per day, ideally about 30 minutes before anticipated stressful activity. Work up to two sprays per nostril as needed once tolerance is assessed. Administer intranasally for optimal CNS absorption.
Warning: Use caution when combining with other GABAergic drugs as interactions are possible. If you experience shortness of breath or significant fatigue, reduce the dose and reassess. Hair loss has been reported in some users, likely related to BDNF activity.
Safety Profile
Drug interactions particularly with other GABAergic compounds, where combined activity on GABA-related pathways could produce additive sedative or depressant effects
Tiredness and fatigue reported by some users, more common at higher doses or when stacked with other calming compounds
Shortness of breath noted as a possible side effect in some users, warranting dose reduction if it occurs
Sinus pain or nasal irritation possible with repeated intranasal administration, manageable with proper spray technique and alternating nostrils
Hair loss reported in a subset of users, potentially linked to BDNF upregulation and its downstream effects on hair follicle cycling
Citations
Semenova, T. P., et al. Anxiolytic and nootropic effects of Selank in experimental models. PubMed. https://pubmed.ncbi.nlm.nih.gov/16960307/
Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.
